| ID: | 130 | |
|---|---|---|
| Name: | Compound 130 | |
| Description: | Original numeration in publication: 14 | |
| Labels: | Training_set, Thiazolidine‐2, 4‐dione | |
| CAS: | ||
| InChi Code: | InChI=1S/C15H10ClN3O3S2/c16-10-3-1-9(2-4-10)7-11-13(21)19(15(22)24-11)8-12(20)18-14-17-5-6-23-14/h1-7H,8H2,(H,17,18,20)/b11-7- |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.14 |
El-Adl, K.; Sakr, H.; El-Hddad, S. S. A. a. E.-H., A.-G. A.; Nasser, M.; Abulkhair, H. S. Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2021, 354, e2000491. https://doi.org/10.1002/ardp.202000491 |
| 6.15117 |
Eq1: VEGFR-2 inhibition (Data used to train model) |